Symposium Agenda
The meeting will feature presentations from invited speakers and poster session, followed by a networking reception. We anticipate attendees from academia, industry, and patient advocacy participants.
This meeting brings together scientists and physicians from academics with industry to foster interdisciplinary communication and collaboration in radiogenomics research, facilitating development of precision radiation therapies. This meeting will provide a unique perspective on the exciting topics of radiation oncology research, precision medicine, radiogenomics, and cancer therapies.
Presentations and discussions will focus on how recent developments in research translate into clinical applications and lifesaving therapeutic options for patients. Our unique programming will provide opportunities for attendees to meet one-on-one with presenters and key opinion leaders.
The Agenda is available here in PDF.
If changes occur to the schedule, the agenda will be updated accordingly.
Keynote Presentation: Potential limitations on the promise of personalized and adaptive RT
Lawrence B. Marks, MD, Dr. Sidney K. Simon Distinguished Professor of Oncology Research, Chair, Radiation Oncology, UNC-Chapel Hill
Keynote Presentation: Utilizing Precision Radiotherapy to Improve the Therapeutic Ratio
Carmen Bergom, MD, PhD, Associate Professor of Radiation Oncology, Washington University School of Medicine in St. Louis
Can we exploit patient-to-patient variability in radiation response for therapeutic gain?
Søren Bentzen, PhD, DMSc, FASTRO, Professor, Director of the Division of Biostatistics & Bioinformatics, University of Maryland School of Medicine
Patient Advocacy Presentation: The long and winding road
Frank Biddle, Patient Advocate
Health Sciences Welcome
David Brenner, MD, Vice Chancellor for Health Sciences, School of Medicine, UC San Diego
Session Introduction
Ezra Cohen, MD, FRCPSC, FASCO, Chief, Division of Hematology/Oncology, Department of Medicine, Moores Cancer Center, UC San Diego
Adaptive Radiotherapy: an Emerging Tool for Precision Radiation Oncology
Heather Curry, MD, Applied Clinical Programs Director, Medical Affairs, Varian, a Siemens Healthineers company
Predictive and adaptive radiotherapy: combining twin revolutions
Joseph Deasy, PhD, Chair, Medical Physics, Memorial Sloan Kettering Cancer Center
Organizer Welcome
Ida Deichaite, PhD, Organizer, Assistant Adjunct Professor, Radiation Medicine & Applied Sciences, Director, Industry Relations, Moores Cancer Center, UC San Diego
Imaging and Molecular Biomarkers for Personalized Radiotherapy
Issam El Naqa, PhD, Chair, Machine Learning, Moffitt Cancer Center
Lessons of QUANTEC and HyTEC: is there a roadmap from population-based analysis to personalized treatment?
Jimm Grimm, PhD, DABR, Lead CyberKnife Physicist, Geisinger Health System, Adjunct Professor, Dept. Medical Imaging and Radiation Sciences, Thomas Jefferson University
Impact of genomic alterations on response to treatment and prognosis in head and neck squamous cell carcinoma
Austin Hopper, MD, Resident Physician, Radiation Medicine & Applied Sciences, UC San Diego
Patient stratification strategies to maximize utilization of adaptive RT platforms
Vitali Moiseenko, PhD, Professor, Radiation Medicine & Applied Sciences, UC San Diego
Personalization through standardization: how automation is enabling precision radiotherapy
Kevin Moore, PhD, Professor & Deputy Division Director of Medical Physics, Assistant Vice Chair for Physics and Technology Research, Radiation Medicine & Applied Sciences, UC San Diego
Radiation Medicine Welcome
AJ Mundt, MD, Chair, Radiation Medicine & Applied Sciences, UC San Diego
Modeling the impact of integral dose in radiation-induced lymphopenia
Harald Paganetti, PhD, Director of Physics Research, Department of Radiation Oncology, Massachusetts General Hospital, Professor of Radiation Oncology, Harvard Medical School
Closing Remarks
Todd Pawlicki, PhD, FAAPM, FASTRO, Professor & Vice Chair, Radiation Medicine, UC San Diego
Personalized radiotherapy: incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicity
Tiziana Rancati, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Identifying the highest priority cervical cancer patients for daily adaptation
Xenia Ray, PhD, Assistant Professor, Radiation Medicine & Applied Sciences, UC San Diego